Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal

Journal: Science Advances

Published: 2020-06-01

DOI: 10.1126/sciadv.aba4353

Affiliations: 28

Authors: 31

Go to article
Institutions Share
UC San Diego Health Sciences, United States of America (USA) 0.38
William Harvey Research Institute (WHRI), QMUL, United Kingdom (UK) 0.10
La Jolla Institute for Immunology (LJI), United States of America (USA) 0.09
University of California, San Diego (UC San Diego), United States of America (USA) 0.06
Showa University, Japan 0.06
Harvard University, United States of America (USA) 0.05
Brigham and Women's Hospital (BWH), United States of America (USA) 0.04
Interuniversity Consortium of Structural and Systems Biology (INBB), Italy 0.04
AstraZeneca Gaithersburg, MD, United States of America (USA) 0.03
McGill University, Canada 0.03
Sahlgrenska Academy, GU, Sweden 0.03
University of Bergen (UIB), Norway 0.02
Tokyo Medical and Dental University (TMDU), Japan 0.01
Jagiellonian University (UJ), Poland 0.01
Partners HealthCare, United States of America (USA) 0.01
Broad Institute of MIT and Harvard, United States of America (USA) 0.01
Karolinska Institute (KI), Sweden 0
The University of Manchester (UoM), United Kingdom (UK) 0

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER